288 Causes of Death Mapped Across 204 Countries Over 30 Years

The Year the World Stopped Getting Healthier

In 2019, a child born in Singapore could expect to live 86 years. A child born in the Central African Republic could expect 54. That gap, brutal as it was, had been shrinking for decades. Then COVID 19 arrived, and in two years, it erased more than a decade of progress in some places. The pandemic didn't just kill people. It rewrote the basic story of global health, a story that the Global Burden of Disease Study (GBD) has been tracking for 30 years. The latest installment of that study, published in The Lancet by Mohsen Naghavi, Kanyin Liane Ong, and a team of hundreds of researchers, maps 288 causes of death across 204 countries from 1990 to 2021 (Naghavi et al., 2024). It is the most comprehensive picture ever assembled of how humans die, and what it reveals is not just a pandemic. It is a quiet revolution in which diseases that once killed everyone, everywhere, are now killing only the poorest.

The study draws on 56,604 data sources, from hospital records to verbal autopsies to cancer registries. It covers 811 subnational locations, which means researchers can compare death rates in a district of India to a district of Brazil. And it tracks 288 causes of death, from ischemic heart disease to measles to self harm. The result is a map of mortality so detailed that it shows not just what kills us, but where, and how fast that is changing.

What Actually Kills People Now

The four leading causes of age standardized death in 2019 were the same as in 1990: ischemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections (Naghavi et al., 2024). For 30 years, these four diseases dominated the global death toll, a grim constant. Then COVID 19 arrived and reshuffled the deck. In 2021, COVID 19 became the second leading cause of death globally, with 94.0 deaths per 100,000 population. Stroke dropped to third. Chronic obstructive pulmonary disease fell to fourth (Naghavi et al., 2024).

But the pandemic did not hit evenly. The highest age standardized death rates from COVID 19 occurred in sub Saharan Africa (271.0 deaths per 100,000) and Latin America and the Caribbean (195.4 deaths per 100,000). The lowest rates were in high income countries (48.1 per 100,000) and southeast Asia, east Asia, and Oceania (23.2 per 100,000) (Naghavi et al., 2024). That 12 fold difference between the worst hit and the least hit regions is not just about biology. It is about infrastructure, vaccine access, and the capacity to respond.

The study also found something that might surprise you. Even with the pandemic, global life expectancy improved overall from 1990 to 2021. But that average hides a brutal two year reversal. Between 2019 and 2021, global life expectancy dropped by 1.6 years, driven almost entirely by COVID 19 and pandemic related mortality (Naghavi et al., 2024). In Latin America and the Caribbean, the drop was 3.6 years. In southeast Asia, east Asia, and Oceania, it was only 0.4 years. The region that gained the most life expectancy over 30 years (8.3 years) also suffered the smallest pandemic loss.

How 56,604 Data Sources Became a Picture of Death

The GBD 2021 cause of death analysis is not a single study. It is a global intelligence operation. Researchers collected data from vital registration systems, verbal autopsies (interviews with family members about how someone died), surveys, censuses, surveillance systems, and cancer registries. They added 199 new country years of vital registration data, 5 country years of surveillance data, 21 country years of verbal autopsy data, and 94 country years of other data types (Naghavi et al., 2024).

Then they fed all of this into the Cause of Death Ensemble model, a statistical tool that tests dozens of different models and combines the best ones. The model generates uncertainty intervals, which are essentially ranges of plausible values. When the study says COVID 19 caused 94.0 deaths per 100,000, the uncertainty interval is 89.2 to 100.0. That means the true number is almost certainly within that range.

The team also made methodological improvements for this round. They expanded the under 5 age group into four new age groups, which allows for finer grained analysis of child mortality. They improved methods for dealing with sparse data, which is crucial for rare causes of death. And they included COVID 19 and pandemic related mortality, which includes excess deaths from causes other than COVID 19, lower respiratory infections, measles, malaria, and pertussis (Naghavi et al., 2024).

The Diseases That Are Now Only Killing the Poor

One of the most striking findings in the study is about concentration. The researchers calculated how many causes of death are now concentrated in locations with less than 50% of the global population. In 1990, 44 causes showed this pattern. By 2021, that number had risen to 53 (Naghavi et al., 2024). In other words, diseases that used to kill people everywhere are now killing only the poorest.

This is most dramatic for enteric infections (diarrheal diseases), lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. These are the classic diseases of poverty. They have been pushed out of wealthy countries by clean water, vaccines, antibiotics, and public health infrastructure. But they remain entrenched in the poorest regions, where they continue to kill millions.

The study does not claim to know exactly why this concentration is happening. But the authors suggest that examining these patterns can reveal where successful public health interventions have been implemented. If a disease has become concentrated in a few locations, that means somewhere else, something worked. Translating those successes to the places where the disease remains is an obvious policy opportunity (Naghavi et al., 2024).

The Life Expectancy Decomposition: What Actually Moved the Needle

The researchers did something clever. They decomposed life expectancy by cause of death, location, and year. This allows them to say, for example, that reductions in deaths from enteric infections added X years to life expectancy in South Asia between 1990 and 2019. The results are a kind of accounting of progress.

Globally, life expectancy improved steadily between 1990 and 2019 for 18 of the 22 investigated causes (Naghavi et al., 2024). The biggest contributors were reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal disorders. These are not glamorous achievements. They are the slow, grinding work of sanitation, vaccination, and basic healthcare.

But the pandemic reversed this. Between 2019 and 2021, the decomposition shows that COVID 19 and pandemic related mortality were the dominant forces pulling life expectancy down. In some regions, the pandemic erased 20 years of progress.

What the Study Does Not Prove

The GBD 2021 study is a descriptive analysis. It tells us what happened, not why. It does not prove that a specific intervention caused a specific decline in mortality. It does not model the effects of policy changes. It does not tell us what to do next.

The study also has limitations that the authors acknowledge. Data quality varies enormously across countries. In some places, vital registration systems are incomplete. Verbal autopsies can be unreliable. The models are only as good as the data they are fed. And the uncertainty intervals for some causes of death, especially in low income countries, are wide.

There is also a question that the study cannot answer. Why did some regions suffer so much more from COVID 19 than others? The data shows the difference. It does not explain it. That is a question for epidemiologists, political scientists, and historians.

What This Actually Means

• ▸The COVID 19 pandemic did not just kill people. It reversed decades of progress in life expectancy, especially in Latin America and the Caribbean, where the loss was 3.6 years. Any serious public health strategy must account for the fact that the next pandemic could be even worse, and the most vulnerable regions are the least prepared.

• ▸The concentration of deadly diseases in the poorest regions is not a failure of medicine. It is a success of public health in wealthy countries. The diseases that used to kill everyone now kill only the poor. That means the solutions exist. The challenge is implementation.

• ▸The four leading causes of death in 2019 were the same as in 1990. This is not inertia. It is progress. The death rates from these diseases have fallen, but they remain the biggest killers because they start from such a high baseline. The next breakthrough in global health will not come from a new drug. It will come from getting existing treatments to the people who still die from preventable causes.

• ▸The GBD study is the best tool we have for tracking global health, but it is only as good as the data it uses. The 56,604 data sources are a testament to human effort, but they also reveal the gaps. Countries with weak vital registration systems are invisible in some ways. Improving data collection is not a luxury. It is a prerequisite for saving lives.

• ▸The pandemic proved that progress is fragile. The 1.6 year drop in global life expectancy between 2019 and 2021 is a warning. The gains of the last 30 years can be lost in two. The question is not whether another shock will come. It is whether we will be ready.